Editorial: Proglucagon-Derived Peptides door Peter R. Flatt, Filip K. Knop, Filip K. Knop, Filip K. Knop, Filip K. Knop, Andrei I. Tarasov

Volledige tekst

Amylin and Calcitonin: Potential Therapeutic Strategies to Reduce Body Weight and Liver Fat door David S. Mathiesen, Asger Lund, Tina Vilsbøll, Tina Vilsbøll, Tina Vilsbøll, Filip K. Knop, Filip K. Knop, Filip K. Knop, Filip K. Knop, Jonatan I. Bagger, Jonatan I. Bagger

Volledige tekst

Future Perspectives on GLP-1 Receptor Agonists and GLP-1/glucagon Receptor Co-agonists in the Treatment of NAFLD door Marta Seghieri, Marta Seghieri, Alexander S. Christensen, Andreas Andersen, Anna Solini, Filip K. Knop, Filip K. Knop, Filip K. Knop, Tina Vilsbøll, Tina Vilsbøll

Volledige tekst

A glucose-insulin-glucagon coupled model of the isoglycemic intravenous glucose infusion experiment door Vijaya Subramanian, Jonatan I. Bagger, Jonatan I. Bagger, Jonatan I. Bagger, Jens J. Holst, Jens J. Holst, Filip K. Knop, Filip K. Knop, Filip K. Knop, Filip K. Knop, Tina Vilsbøll, Tina Vilsbøll, Tina Vilsbøll

Volledige tekst

Glucagon Receptor Signaling and Lipid Metabolism door Katrine D. Galsgaard, Katrine D. Galsgaard, Jens Pedersen, Jens Pedersen, Filip K. Knop, Filip K. Knop, Filip K. Knop, Jens J. Holst, Jens J. Holst, Nicolai J. Wewer Albrechtsen, Nicolai J. Wewer Albrechtsen, Nicolai J. Wewer Albrechtsen

Volledige tekst

Hypoglycaemia and cardiac arrhythmias in diabetes door Andreas Andersen, Peter G. Jørgensen, Filip K. Knop, Tina Vilsbøll

Volledige tekst

Bone Status in Obese, Non-diabetic, Antipsychotic-Treated Patients, and Effects of the Glucagon-Like Peptide-1 Receptor Agonist Exenatide on Bone Turnover Markers and Bone Mineral... door Robert Eriksson, Robert Eriksson, Brian V. Broberg, Pelle L. Ishøy, Nikolaj Bak, Ulrik B. Andersen, Niklas R. Jørgensen, Niklas R. Jørgensen, Filip K. Knop, Filip K. Knop, Filip K. Knop, Bjørn H. Ebdrup, Bjørn H. Ebdrup, Bjørn H. Ebdrup

Volledige tekst

Accuracy of continuous glucose monitoring during exercise-related hypoglycemia in individuals with type 1 diabetes door Kaisar Maytham, Kaisar Maytham, Per G. Hagelqvist, Per G. Hagelqvist, Susanne Engberg, Julie L. Forman, Ulrik Pedersen-Bjergaard, Ulrik Pedersen-Bjergaard, Filip K. Knop, Filip K. Knop, Filip K. Knop, Tina Vilsbøll, Tina Vilsbøll, Tina Vilsbøll, Andreas Andersen, Andreas Andersen

Volledige tekst

Incretin mimetics: a novel therapeutic option for patients with type 2 diabetes – a review door Katrine B Hansen, Tina Vilsbøll, Filip K Knop

Volledige tekst

Protocol for assessing the effects of exogenous hormone administration on human postprandial glucose metabolism, appetite sensations, and food intake door Christoffer A. Hagemann, Lærke S. Gasbjerg, Mikkel B. Christensen, Filip K. Knop

Volledige tekst

Two weeks of acarbose treatment shows no effect on gut microbiome composition in patients with type 2 diabetes: a randomised, placebocontrolled, double-blind, crossover study door Niels B Dalsgaard, Lærke S Gasbjerg, Laura S Hansen, Dennis S Nielsen, Torben S Rasmussen, Filip K Knop

Volledige tekst

Mechanisms of the incretin effect in subjects with normal glucose tolerance and patients with type 2 diabetes. door Andrea Mari, Jonatan I Bagger, Ele Ferrannini, Jens J Holst, Filip K Knop, Tina Vilsbøll

Volledige tekst

Model‐Based Prediction of Plasma Concentration and Enterohepatic Circulation of Total Bile Acids in Humans door Benjamin Guiastrennec, David P. Sonne, Martin Bergstrand, Tina Vilsbøll, Filip K. Knop, Mats O. Karlsson

Volledige tekst

No changes in levels of bone formation and resorption markers following a broad-spectrum antibiotic course door Kristian H. Mikkelsen, Tina Vilsbøll, Jens J. Holst, Bolette Hartmann, Filip K. Knop, Morten Frost

Volledige tekst

Metabolic profile in patients with newly diagnosed bipolar disorder and their unaffected first-degree relatives door Klara Coello, Maj Vinberg, Filip K. Knop, Bente K. Pedersen, Roger S. McIntyre, Lars V. Kessing, Klaus Munkholm

Volledige tekst

Benefits and Harms of Sodium-Glucose Co-Transporter 2 Inhibitors in Patients with Type 2 Diabetes: A Systematic Review and Meta-Analysis. door Heidi Storgaard, Lise L Gluud, Cathy Bennett, Magnus F Grøndahl, Mikkel B Christensen, Filip K Knop, Tina Vilsbøll

Volledige tekst

Supportive and non-supportive interactions in families with a type 2 diabetes patient: an integrative review door Birgitte B. Bennich, Michael E. Røder, Dorthe Overgaard, Ingrid Egerod, Lene Munch, Filip K. Knop, Tina Vilsbøll, Hanne Konradsen

Volledige tekst

Separate and combined effects of long-term GIP and GLP-1 receptor activation in patients with type 2 diabetes: a structured summary of a study protocol for a double-blind, randomis... door Tina Vilsbøll, Filip K Knop, Mads M Helsted, Lærke S Gasbjerg, Casper K Nielsen, Julie L Forman, Mikkel B Christensen

Volledige tekst

Semaglutide treatment for PRevention Of Toxicity in high-dosE Chemotherapy with autologous haematopoietic stem-cell Transplantation (PROTECT): study protocol for a randomised, doub... door Filip K Knop, Hannelouise Kissow, Maria Ebbesen Sørum, Anne Ortved Gang, Dorte Maegaard Tholstrup, Sif Gudbrandsdottir, Brian Kornblit, Klaus Müller

Volledige tekst

evoke and evoke+: design of two large-scale, double-blind, placebo-controlled, phase 3 studies evaluating efficacy, safety, and tolerability of semaglutide in early-stage symptomat... door Jeffrey L. Cummings, Alireza Atri, Howard H. Feldman, Oskar Hansson, Mary Sano, Filip K. Knop, Peter Johannsen, Teresa León, Philip Scheltens

Volledige tekst